Characterization of a 60-kDa cell surface-associated transforming growth factor-β binding protein that can interfere with transforming growth factor-β receptor binding

Journal of Cellular Physiology

Volumn 173, Issue 3, 1997, Pages 447-459

  Piek, Ester ^a   Franzén, Petra ^b   Heldin, Carl Henrik ^b   Ten Dijke, Peter ^b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BINDING PROTEIN; CELL SURFACE PROTEIN; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

AFFINITY LABELING; ARTICLE; CELL CULTURE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; CYTOCHEMISTRY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN ANALYSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; BINDING SITES; CARRIER PROTEINS; CELL DIVISION; CELL MEMBRANE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; LATENT TGF-BETA BINDING PROTEINS; LIGANDS; MALE; MOLECULAR WEIGHT; PROSTATIC NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030856858     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199712)173:3<447::AID-JCP17>3.0.CO;2-8     Document Type: Article

References (53)

1. Andres, J.L., Stanley, K., Cheifetz, S., and Massagué, J. (1989) Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta. J. Cell Biol., 109:3137-3145.
2. Anzano, M.A., Roberts, A.B., Smith, J.M., Sporn, M.B., and De Larco, J.E. (1983) Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Proc. Natl. Acad. Sci. USA, 80:6264-6268.
3. Attisano, L., Wrana, J.L., Montalvo, E., and Massagúe, J. (1996) Activation of signaling by the activin receptor complex. Mol. Cell. Biol., 16:1066-1073.
4. Brown, W.M., Saunders, N.R., Møllgård, K., and Dziegielewska, K.M. (1992) Fetuin - An old friend revisited. Bioessays, 14:749-755.
5. Bützow, R., Fukushima, D., Twardzik, D.R., and Ruoslahti, E. (1993) A 60-kD protein mediates the binding of transforming growth factor-β to cell surface and extracellular matrix proteoglycans. J. Cell Biol., 122:721-727.
6. Carruba G., Leake, R.E., Rinaldi, F., Chalmers, D., Comito, L., Sorci, C., Pavone-Macaluso, M., and Castagnetta, L.A. (1994) Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cell. Steroids, 59:412-420.
7. Cheifetz, S., and Massagué, J. (1991) Isoform-specific transforming growth factor-β binding proteins with membrane attachments sensitive to phosphatidylinositol-specific phospholipase C. J. Biol. Chem., 266:20767-20772.
8. Cheifetz, S., Ling, N., Guillemin, R., and Massagué, J. (1988) A surface component on GH3 pituitary cells that recognizes transforming growth factor-β, activin and inhibin. J. Biol. Chem., 263:17225-17228.
9. Cheifetz, S., Hernandez, H., Laiho, M., Iwata, K.K., ten Dijke, P., and Massagué, J. (1990) Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J. Biol. Chem., 265:20533-20538.
10. Cheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabeu, C., Massagué, J., and Letarte, M. (1992) Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J. Biol. Chem., 267:19027-19030.
11. Demetriou, M., Binkert, C., Sukhu, B., Tenenbaum, H.C., and Dennis, J.W. (1996) Fetuin/α2-HS glycoprotein is a transforming growth factor-β type II receptor mimic and cytokine antagonist. J. Biol. Chem., 271:12755-12761.
12. Dumont, N., O'Connor-McCourt, M.D., and Philip, A. (1995) Transforming growth factor-β receptors on human endometrial cells: Identification of the type I, II and III receptors and glycosyl-phosphatidylinositol anchored TGF-β binding proteins. Mol. Cell. Endocrinol., 111:57-66.
13. Dziegielewska, K.M., Brown, W.M., Casey, S.-J., Christie, D.L., Foreman, R.C., Hill, R.M., and Saunders, N.R. (1990) The complete cDNA and amino acid sequence of bovine fetuin. Its homology with α2HS glycoprotein and relation to other members of the cystatin superfamily. J. Biol. Chem., 265:4354-4357.
14. Fava, R.A., and McClure, D.B. (1987) Fibronectin-associated transforming growth factor. J. Cell. Physiol., 131:184-189.
15. Filmus, J., and Kerbel, R.S. (1993) Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression. Curr. Opin. Oncol., 5:123-129.
16. Fong, C.J., Sutkowski, D.M., Braun, E.J., Bauer, K.D., Sherwood, E.R., Lee, C., and Kozlowski, J.M. (1993) Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells. J. Urol., 149:1190-1194.
17. Franzén, P., Ichijo, H., and Miyazono, K. (1993a) Different signals mediate transforming growth factor-β1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp. Cell Res., 207:1-7.
18. Franzén, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.-H., and Miyazono, K. (1993b) Identification of a TGF-β type I receptor as a novel member of the serine/threonine kinase receptor family. Cell, 75:681-692.
19. Frolik, C.A., Wakefield, L.M., Smith, D.M., and Sporn, M.B. (1984) Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J. Biol. Chem., 259:10995-11000.
20. Ichijo, H., Yamashita, H., ten Dijke, P., Eto, Y., Heldin, C.-H., and Miyazono, K. (1993) Characterization of in vivo phosphorylation of activin type II receptor. Biochem. Biophys. Res. Commun., 194:1508-1514.
21. Inouye, S., Ling, N., and Shimasaki, S. (1992) Localization of the heparin binding site of follistatin. Mol. Cell. Endocrinol., 90:1-6.
22. Janssen, T., Kiss, R., Dedecker, R., Petein, M., Pasteels, J.L., and Schulman, C. (1995) Influence of dihydrotestosterone, epidermal growth factor, and basic fibroblast growth factor on the cell kinetics of the PC3, DU145, and LNCaP prostatic cancer cell lines: Relationship with DNA ploidy level. Prostate, 27:277-286.
23. Kim, I.Y., Ahn, H.-J., Zelner, D.J., Shaw, J.W., Sensibar, J.A., Kim, J.-H., Kato, M., and Lee, C. (1996a) Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res., 56:44-48.
24. Kim, I.Y., Kim, J.-H., Zelner, D.J., Ahn, H.-J., Sensibar, J.A., and Lee, C. (1996b) Transforming growth factor-β1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cell line. LNCaP. Endocrinology, 137:991-999.
25. Kim, I.Y., Zelner, D.J., Sensibar, J.A., Ahn, H.-J., Park, L., Kim, J.-H., and Lee, C. (1996c) Modulation of sensitivity to transforming growth factor-β1 (TGF-β1) and the level of type II TGF-β receptor in LNCaP cells by dihydrotestosterone. Exp. Cell Res., 222:103-110.
26. Lee, C., Sutkowski D.M., Sensibar, J.A., Zelner, D., Kim, I., Amsel, I., Shaw, N., Prins, G.S., and Kozlowski, J.M. (1995) Regulation of proliferation and production of prostate specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology, 136:796-803.
27. Lopéz-Casillas, F., Cheifetz, S., Doody, J., Andres, J.L., Lane, W.S., and Massagué, J. (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell, 67:785-795.
28. MacKay, K., and Danielpour, D. (1991) Novel 150- and 180-kDa glycoproteins that bind transforming growth factor (TGF)-β1 but not TGF-β2 are present in several cell lines. J. Biol. Chem., 266:9907-9911.
29. MacKay, K., Robbins, A.R., Bruce, M.D., and Danielpour, D. (1990) Identification of disulfide-linked transforming growth factor-beta 1-specific binding proteins in rat glomeruli. J. Biol. Chem., 265:9351-9356.
30. Massagué, J. (1990) The transforming growth factor-β family. Annu. Rev. Cell Biol., 6:597-641.
31. Massagué, J. (1996) TGF-beta signaling: Receptors, transducers, and mad proteins. Cell, 85:947-950.
32. Murphy-Ullrich, J.E., Schultz-Cherry, S., and Hook, M. (1992) Transforming growth factor-beta complexes with thrombospondin. Mol. Biol. Cell,3:181-188.
33. O'Connor-McCourt, M.D., and Wakefield, L.M. (1987) Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. J. Biol. Chem., 262:14090-14099.
34. O'Grady, P., Kuo, M.-D., Baldassare, J.J., Huang, S.S., and Huang, J.S. (1991) Purification of a new type high molecular weight receptor (type V receptor) of transforming growth factor beta (TGF-beta) from bovine liver. Identification of the type V TGF-beta receptor in cultured cells. J. Biol. Chem., 266:8583-8589.
35. Paralkar, M.V., Vukicevic, S., and Reddi, A.H. (1991) Transforming growth factor-beta type 1 binds to collagen IV of basement membrane matrix: Implications for development. Dev. Biol., 143:303-308.
36. Roberts, A.B., and Sporn, M.B. (1990) Transforming growth factor-βs. In: Peptide Growth Factors and Their Receptors, Part 1. M.B. Sporn and A.B. Roberts, eds. Springer Verlag, Berlin, pp. 419-472.
37. Rosenzweig, B.L., Imamura, T., Okadome, T., Cox, G.N., Yamashita, H., ten Dijke, P., Heldin, C.-H., and Miyazono, K. (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. USA, 92:7632-7636.
38. Schutte M., Hruban, R.H., Hedrick, L., Cho, K.R., Nadasdy, G.M., Weinstein, C.L., Bova, G.S., Isaacs, W.B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R.A., Jr., Meltzer, P.S., Hahn, S.A., and Kern, S.E. (1996) DPC4 gene in various tumor types. Cancer Res., 56:2527-2530.
39. Schuurmans, A.L.G., Bolt, J., and Mulder, E. (1988) Androgens stimulate both the growth rate and epidermal growth factor receptor activity of the human prostate tumor cell line LNCaP. Prostate, 12:55-64.
40. Schuurmans, A.L.G, Bolt, J., Veldscholte, J., and Mulder, E. (1991) Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J. Steroid Biochem. Mol. Biol., 40:193-197.
41. Shah, M., Foreman, D.M., and Ferguson, M.W. (1995) Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci., 108:985-1002.
42. Sonnenschein, C., Olea, N., Pasanen, M.E., and Soto, A.M. (1989) Negative controls of cell proliferation: Human prostate cancer cells and andogens. Cancer Res., 49:3474-3481.
43. Sugino, K., Kurosawa, N., Nakamura, T., Takio, K., Shimasaki, S., Ling, N., Titani, K., and Sugino, H. (1993) Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxy-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. J. Biol. Chem., 268:15579-15587.
44. ten Dijke, P., Franzén, P., Yamashita, H., Ichijo, H., Heldin, C.-H., and Miyazono, K. (1994a) Serine/Threonine kinase receptors. Progr. Growth Factor Res., 5:55-72.
45. ten Dijke, P., Yamashita, H., Ichijo, H., Franzén, P., Laiho, M., Miyazono, K., and Heldin, C.-H. (1994b) Characterization of type I receptors for transforming growth factor-β and activin. Science, 264:101-104.
46. ten Dijke, P., Miyazono, K., and Heldin, C.-H. (1996) Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr. Opin. Cell Biol., 8:139-145.
47. Ueno, N., Ling, N., Ying, S.Y., Esch, F., Shimasaki, S., and Guillemin, R. (1987) Isolation and partial characterization of follistatin: A single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc. Natl. Acad. Sci. USA, 84:8882-8286.
48. Wang, X.-F., Lin, H.Y., Ng-Eaton, E., Downward, J., Lodish, H.F., and Weinberg, R.A. (1991) Expression cloning and characterization of the TGF-β type III receptor. Cell, 67:797-805.
49. Wilding, G., Zugmeier, G., Knabbe, C., Flanders, K., and Gelmann, E. (1989) Differential effects of transforming growth factor β on human prostate cancer cells in vitro. Mol. Cell. Endocrinol., 62:79-87.
50. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. (1994) Mechanism of activation of TGF-β receptor. Nature, 370:341-347.
51. Yamaguchi, Y., Mann, D.M., and Ruoslahti, E. (1990) Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature, 346:281-284.
52. Yamashita, H., Ichijo, H., Grimsby, S., Morén, A., ten Dijke, P., and Miyazono, K. (1994) Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β. J. Biol. chem., 269:1995-2001.
53. Yamashita, H., Okadome, T., Franzén, P., ten Dijke, P., Heldin, C.-H., and Miyazono, K. (1995) A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-β. J. Biol. Chem., 270:770-774.